These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 4746315)

  • 21. Insulin antibodies and the control of diabetes.
    Dixon K; Exon PD; Malins JM
    Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin antibody formation during long-term treatment with monocomponent and monospecies insulin.
    Piers DA; Sluiter WJ; Reitsma WD; Doorenbos H
    Neth J Med; 1974; 17(4-5):234-8. PubMed ID: 4465730
    [No Abstract]   [Full Text] [Related]  

  • 23. [Proceedings: 2 years of experiences with monocomponent insulin in diabetic patients].
    Fankhauser S; Michl J; Morell B
    Helv Med Acta; 1974 May; 37(5-6):365-6. PubMed ID: 4605883
    [No Abstract]   [Full Text] [Related]  

  • 24. [Insulin antibody titres--observations on their course in patients with diabetes mellitus. A case report].
    Grüneklee D; Takaishi T; Daweke H
    Munch Med Wochenschr; 1970 Jul; 112(27):1287-91. PubMed ID: 4193069
    [No Abstract]   [Full Text] [Related]  

  • 25. [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin].
    Iavicoli M; Di Mario U; Coronel GA; Musacchio N; Arduini P
    Minerva Endocrinol; 1984; 9(2):115-20. PubMed ID: 6390124
    [No Abstract]   [Full Text] [Related]  

  • 26. [Insulin antibodies in untreated and insulin-treated diabetics].
    Ditsov S; Penchev I; Andreev D; Sirakov L; Turkolev N
    Vutr Boles; 1972; 11(3):95-9. PubMed ID: 4679989
    [No Abstract]   [Full Text] [Related]  

  • 27. Insulin antibodies--do they matter?
    Walford S
    Neth J Med; 1985; 28 Suppl 1():47-9. PubMed ID: 3892339
    [No Abstract]   [Full Text] [Related]  

  • 28. Circulating antibodies in diabetics treated with conventional and purified insulins.
    Klaff LJ; Vinik AI; Berelowitz M; Jackson WP
    S Afr Med J; 1978 Jul; 54(4):149-53. PubMed ID: 694712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human anti-insulin antibodies.
    Faulk WP; Karam JH; Fudenberg HH
    J Immunol; 1971 Apr; 106(4):1112-6. PubMed ID: 5102837
    [No Abstract]   [Full Text] [Related]  

  • 30. Diabetes mellitus and immunity.
    Mincu I; Cheţa D
    Med Interne; 1983; 21(4):257-66. PubMed ID: 6361973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trial with monocomponent lente insulins. Preliminary report.
    Bruni B; D'Alberto M; Osenda M; Ricci C; Turco GL
    Diabetologia; 1973 Dec; 9(6):492-8. PubMed ID: 4589824
    [No Abstract]   [Full Text] [Related]  

  • 32. [Insulin radioimmunoassay in humans].
    López Quijada C; Fernández-Cruz A; Blázquez E; Salinas M
    Rev Clin Esp; 1968 Oct; 111(1):17-26. PubMed ID: 5742412
    [No Abstract]   [Full Text] [Related]  

  • 33. [Is proinsulin contamination of commercial insulin preparations responsible for the stimulation of insulin antibodies?].
    Kerp L; Steinhilber S; Kasemir H
    Klin Wochenschr; 1970 Jul; 48(14):884-5. PubMed ID: 5535446
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter: Antigenicity of "monocomponent" insulins.
    Yue DK; Turtle JR
    Lancet; 1974 Oct; 2(7887):1022. PubMed ID: 4138266
    [No Abstract]   [Full Text] [Related]  

  • 35. [Glucagon antibodies in the blood of insulin-treated diabetics (effect of monospecific and monocomponent insulin therapy on antibody level)].
    Korányi L; Tamás G; Gerö L; Halmos T; Baranyai E; Büki B
    Orv Hetil; 1981 Jun; 122(23):1371-4. PubMed ID: 7024892
    [No Abstract]   [Full Text] [Related]  

  • 36. [Serum I-125 insulin IgG binding capacity in diabetic patients on a long-term insulin treatment, with reference to indications for monocomponent insulin therapy].
    Bruni B; Castellazzi R; Osenda M; Papotti G; Turco GL
    Minerva Med; 1974 Mar; 65(20):1071-7. PubMed ID: 4827592
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of labeled insulin for a study of insulin antibodies. II. Study of antibodies in a patient with resistance to insulin].
    Foit R; Sieberová R; Kraml J; Prokes J; Zikmund E
    Vnitr Lek; 1968 Jun; 14(6):530-8. PubMed ID: 5661807
    [No Abstract]   [Full Text] [Related]  

  • 38. A method for determination of anti-insulin antibodies in the plasma of insulin-treated diabetics.
    Sekso M; Resetić J; Riznar V; Solter M
    Acta Med Iugosl; 1978; 32(2):125-34. PubMed ID: 665291
    [No Abstract]   [Full Text] [Related]  

  • 39. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
    Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
    Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated circulating proinsulin levels in insulin-requiring diabetic patients.
    Block MB; Mako M; Steiner DF; Rubenstein AH
    J Lab Clin Med; 1971 Nov; 78(5):811-2. PubMed ID: 5316079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.